-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Glutathione S-Transferase T1 and M1 Gene Polymorphisms among Breast Cancer Susceptible Ghanaians
Benjamin Arko-Boham, Emmanuel Ayitey Tagoe, BerniceAdjorogbe, Nii Ayite Aryee, Samuel M Adadey, Osborne Quaye, Joe-Nat Clegg-Lamptey
Research Paper: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Challenges of combining cytotoxic chemotherapy and tyrosine kinase inhibitors
Michael P Chu, Vijaya L Damaraju & Michael B Sawyer
Perspective: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
Edoxaban: a new oral direct factor Xa inhibitor for the prevention and treatment of thromboembolic disorders
Rupert Bauersachs
Clinical Trail Outcomes: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
How can we manage resistance to antiangiogenic drugs?
Dai Chu Luu, Joseph Chao
Editorial: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Strategies to overcome endocrine therapy resistance in hormone receptor-positive advanced breast cancer
Rowan T Chlebowski
Review: Clinical Trail Outcomes: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Metastatic melanoma can be cured: advances in immunotherapy and targeted approaches
Walter J Urba, Brendan D Curti
Editorial: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Corrigendum: Clin Invest (2011) 1(1) 145156.
Editor\\\'s Note: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pharmacogenomic testing to guide treatment using antipsychotic medications
David A Mrazek
Therapeutic Prospective: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA
Lisa Mathis, Hong Vu & Andrew E Mulberg
Editorial: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation
-
Immunosuppression and renal transplant rejection: review of current and emerging therapies
Roberto Marcen
Review Article: Clinical Investigation